LOGIN  |  REGISTER

Recent Insider Transactions - Keros Therapeutics (NASDAQ: KROS)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ KROS Keros Therapeutics
Pontifax Management 4 G.P. (2015) Ltd. / 10 percent owner
10/15/2025
Sell
$17.75
155,262
$2.756M
0
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
10/15/2025
Sell
$17.75
743,358
$13.195M
0